Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher G Goetz

Showing results (181-190 of 313) with videos related to

Pageof 32
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|March 24, 2009
Determinants of quality of life in children with Gilles de la Tourette syndromeBryan A Bernard, Glenn T Stebbins, Sandra Siegel, et al.
Movement Disorders Clinical Practice|March 7, 2019
Clinimetric Properties of the Fragile X-associated Tremor Ataxia Syndrome Rating ScaleDeborah A Hall, Glenn T Stebbins, Sebastien Jacquemont, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 17, 2016
Parkinson's disease-related fatigue: A case definition and recommendations for clinical researchBenzi M Kluger, Karen Herlofson, Kelvin L Chou, et al.
Movement Disorders Clinical Practice|August 11, 2020
Measuring Medication Adherence in Parkinson's Disease: A Systematic Review of Contributing Components in Rating ScalesMichelle H S Tosin, Glenn T Stebbins, Christopher G Goetz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 14, 2008
Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: a double blind video-based analysisC Warren Olanow, Jean-Michel Gracies, Christopher G Goetz, et al.
Movement Disorders Clinical Practice|March 12, 2024
Co-Existent Probable RBD and PD: Disease Progression, Medication Response, and Clinical Trial ImplicationsHaotian Zou, Yuanyuan Guo, Christopher G Goetz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 16, 2022
Dissecting the Domains of Parkinson's Disease: Insights from Longitudinal Item Response Theory ModelingSheng Luo, Haotian Zou, Glenn T Stebbins, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 25, 2011
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's diseaseSusan H Fox, Regina Katzenschlager, Shen-Yang Lim, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 3, 2006
Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's diseaseJoseph H Friedman, Robert M Berman, Christopher G Goetz, et al.
Clinical Trials (London, England)|January 21, 2006
Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trialsPaulo Guimaraes, Karl Kieburtz, Christopher G Goetz, et al.
Pageof 32

Showing results (181-190 of 313) with videos related to

Sort By:
Pageof 32
Movement Disorders : Official Journal of the Movement Disorder Society|March 24, 2009
Determinants of quality of life in children with Gilles de la Tourette syndromeBryan A Bernard, Glenn T Stebbins, Sandra Siegel, et al.
Movement Disorders Clinical Practice|March 7, 2019
Clinimetric Properties of the Fragile X-associated Tremor Ataxia Syndrome Rating ScaleDeborah A Hall, Glenn T Stebbins, Sebastien Jacquemont, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 17, 2016
Parkinson's disease-related fatigue: A case definition and recommendations for clinical researchBenzi M Kluger, Karen Herlofson, Kelvin L Chou, et al.
Movement Disorders Clinical Practice|August 11, 2020
Measuring Medication Adherence in Parkinson's Disease: A Systematic Review of Contributing Components in Rating ScalesMichelle H S Tosin, Glenn T Stebbins, Christopher G Goetz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 14, 2008
Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: a double blind video-based analysisC Warren Olanow, Jean-Michel Gracies, Christopher G Goetz, et al.
Movement Disorders Clinical Practice|March 12, 2024
Co-Existent Probable RBD and PD: Disease Progression, Medication Response, and Clinical Trial ImplicationsHaotian Zou, Yuanyuan Guo, Christopher G Goetz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 16, 2022
Dissecting the Domains of Parkinson's Disease: Insights from Longitudinal Item Response Theory ModelingSheng Luo, Haotian Zou, Glenn T Stebbins, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 25, 2011
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's diseaseSusan H Fox, Regina Katzenschlager, Shen-Yang Lim, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 3, 2006
Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's diseaseJoseph H Friedman, Robert M Berman, Christopher G Goetz, et al.
Clinical Trials (London, England)|January 21, 2006
Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trialsPaulo Guimaraes, Karl Kieburtz, Christopher G Goetz, et al.
Pageof 32